World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments

 

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

Managing the drug discovery process and technologies has become one of the top challenges faced by the global pharma industry in the recent past; herein lies the opportunity for a spate of companies focusing on contract research in drug discovery. This report presents the opportunities in the top ten segments, where basic research/drug discovery is outsourced globally. The segments covered include outsourcing of research in oncology, central nervous system, autoimmune/inflammation, cardiovascular, infectious diseases, broad-based screening, chemistry, genomic targets, metabolism, and gene therapy.

Table of Contents

World Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, Executive SummaryExecutive SummaryExecutive SummaryWorld Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, OverviewOverviewIntroductionScope of ReportChallengesChallengesEstablishing CredibilityDeveloping Strategic Fit between Outsourcers and CROMoving up the Value ChainDriversMarket DriversGlobal R&D ProductivityCost Advantages Leading to Growth in OutsourcingIncrease in Time and Labor Intensive R&D ProcessesRestraintsMarket RestraintsLack of Strong IPR ProtectionLack of Domain Expertise Limiting CR OpportunitiesUnavailability of World-Class Infrastructure and ManpowerWorld Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, Top Ten Segments and Top Outsourcers of Drug DiscoveryOncologyOverviewAMGENPfizerGlaxoSmithKlineHoffmann-La RocheJohnson & JohnsonCentral Nervous System (CNS)OverviewAmgenGlaxoSmithKlineTaisho PharmaceuticalsEli LillyNovartis AGAutoimmune/InflammationOverviewEli LillySuntory PharmaceuticalProcter & GambleEncysive PharmaceuticalsNovartis AGCardiovascular (CVS)OverviewSchering-Plough CorporationBayer AGGlaxoSmithKlineEli LillyChiron CorporationInfectious DiseasesOverviewPfizerHoffmann-La RocheGlaxoSmithKlineAbbott LaboratoriesImmuno-Designed Molecules SABroad-based ScreeningOverviewPfizerProcter & GambleEli LillyMerck & CoNovartis AGChemistryOverviewNovartis AGAventis PharmaceuticalsEli LillyBayer AGPfizerGenomic TargetsOverviewHoffmann-La RocheBASF AGThe Dow Chemical CompanyE.I. du Pont de Nemours and Company Bayer AGMetabolismOverviewGenzyme CorporationJohnson & JohnsonSchering-Plough CorporationPfizerKirin BreweryGene TherapyOverviewAventis PharmaceuticalsJapan Tobacco IncSchering AGCelltech GroupTranskaryotic Therapies IncWorld Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, Market Opportunity AnalysisAnalysisIntroductionSegment-wise AnalysisMarket TrendsTrendsWorld Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, Sustainable Growth StrategiesEntry StrategiesSelecting the Right SegmentDevelop Innovative Technology PlatformsSelecting the Right PartnerGrowth StrategiesFocus on Strong OutsourcersFocus on Therapeutic Areas Witnessing Cutting-Edge ResearchBuild a Strong ReputationWorld Drug Discovery Contract Research Markets - A Strategic Analysis of Research Opportunities in Top Ten Segments, Database of Key Industry ParticipantsDatabase of Key OutsourcersList of Companies




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.